Impact BioMedical Inc.
IBO
Rank in Stocks
#24221
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on... Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Share Price
$4.01
Last synced: 2026-11-09
Market Cap
$34.65M
Change (1 day)
-2.43%
Change (1 year)
670.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Impact BioMedical Inc. (IBO)
Category
Healthcare
EPS for Impact BioMedical Inc. (IBO)
EPS as of June 2026 TTM: $-1.23
According to Impact BioMedical Inc.'s latest financial reports, its current EPS (TTM) is $-1.23. At the end of 2025 the company had an EPS of $-4.80, a decrease compared to its 2024 EPS of $-0.09.
EPS history for Impact BioMedical Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.23 | -74.38% |
| 2025 | $-4.80 | 5,405.86% |
| 2024 | $-0.09 | -90.14% |
| 2023 | $-0.88 | -88.52% |
| 2022 | $-7.70 | 0.00% |
| 2021 | $-7.70 | 1,075.30% |
| 2020 | $-0.66 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,373.17% |
US
|
|
| $-7.07 | 474.80% |
US
|
|
| $-5.29 | 330.08% |
AU
|
|
| $12.88 | -1,147.16% |
BE
|
|
| $21.56 | -1,852.85% |
NL
|
Questions about Impact BioMedical Inc.'s earnings per share (EPS)
What is Impact BioMedical Inc.'s earnings per share (EPS)?
Impact BioMedical Inc.'s earnings per share (EPS) over the last twelve months is $-1.23, as of Jun 2026.
What was Impact BioMedical Inc.'s earnings per share (EPS) in 2025?
In 2025, Impact BioMedical Inc.'s earnings per share (EPS) was $-4.80, compared with $-0.09 in 2024.
How has Impact BioMedical Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Impact BioMedical Inc.'s earnings per share (EPS) was highest in 2024 ($-0.09) and lowest in 2022 ($-7.70).
How does Impact BioMedical Inc.'s earnings per share (EPS) compare with similar companies?
Impact BioMedical Inc.'s earnings per share (EPS) ($-1.23) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.